ADMA Biologics’ Shares Experience a Drop in Value What Happened? ADMA Biologics, a company that has shown remarkable growth over the past year, recently saw a significant decrease in the value of its shares. In just one month, the company’s shares lost 8.9% of their value, leaving investors wondering what might have caused this sudden…
Paris, France and Cambridge, Massachusetts–(Newsfile Corp. – January 27, 2025) – Biophytis SA (FP: ALBPS) Biophytis SA to Participate in Biomed Forum in Paris Biophytis SA, a clinical-stage biotechnology company specializing in the development of treatments for age-related diseases, has announced its participation in the Biomed Forum organized by All Invest Securities on February 4,…
The XRP Ledger Upgrade: AMM Feature for RLUSD and Steady XRP Prices Exciting Changes Coming to XRP Ledger The XRP Ledger (XRPL) is ramping up for a game-changing upgrade with the introduction of an Automated Market Maker (AMM) feature for RLUSD. This new feature is set to revolutionize the way users interact with the XRP…
The Power of Anticipating and Monetizing Trends: A Game-Changer for Businesses and Investors In today’s ever-evolving business landscape, the ability to accurately predict and monetize emerging trends is becoming increasingly crucial for companies and management teams. This skill set not only sets them apart from their competitors but also opens up new opportunities for substantial…
Rosen Law Firm Investigates Potential Securities Claims Against Perpetua Resources Corp. What You Need to Know Rosen Law Firm, a global investor rights law firm, has announced an investigation of potential securities claims on behalf of shareholders of Perpetua Resources Corp. (NASDAQ:PPTA). The investigation stems from allegations that Perpetua Resources may have issued materially misleading…
NurExone Biologic Inc. Receives Orphan Medicinal Product Designation for ExoPTEN Therapy TORONTO and HAIFA, Israel, Nov. 13, 2024 (GLOBE NEWSWIRE) NurExone Biologic Inc. has recently announced that the European Medicines Agency has granted Orphan Medicinal Product Designation for the company’s ExoPTEN therapy. This is a significant milestone for NurExone, a biopharmaceutical company focused on developing…
What You Need to Know About the Ampio Pharmaceuticals Class Action Lawsuit A Brief Overview In a recent announcement, the Rosen Law Firm, a global investor rights law firm, has filed a class action lawsuit on behalf of purchasers of Ampio Pharmaceuticals, Inc. (NYSE American: AMPE) securities. The lawsuit covers a period between December 29,…
DOJ Sues Apple for Monopoly Attacking Apple’s App Store Policies The United States Department of Justice (DOJ) has taken a significant step in the ongoing battle against tech giant Apple by filing a lawsuit that alleges antitrust violations related to the company’s App Store policies. This legal action comes as a result of concerns that…
